Mapping melanoma lymphoscintigraphy data onto a 3D anatomically based model by Reynolds, HM, Dunbar, PR, Uren, RF, Thompson, JF, Smith, NP

Phase‐3 international trial of adjuvant whole brain radiotherapy (WBRT) or observation (Obs) following local treatment of 1‐3 melanoma brain metastases (MBMs) by Fogarty, GB, Dolven-Jacobsen, K, Morton, RL, Hruby, G, Nowak, AK, Vardy, JL, Drummond, KJ, Dhillon, HM, Mandel, C, Scolyer, RA, Shivalingam, B, Middleton, MR, Burmeister, B, Roos, DE, Lo, SN, Reisse, CH, Paton, EJ, Williams, NC, Thompson, JF, Hong, A

Tumour gene expression signature in primary melanoma predicts long-term outcomes by Garg, M, Couturier, D-L, Nsengimana, J, Fonseca, NA, Wongchenko, M, Yan, Y, Lauss, M, Jönsson, GB, Newton-Bishop, J, Parkinson, C, Middleton, MR, Bishop, T, Sarah, M, Stefanos, N, Tadross, J, Vergara, IA, Lo, S, Felicity, N, Wilmott, JS, Thompson, JF, Long, GV, Scolyer, RA, Corrie, P, Adams, DJ, Brazma, A, Rabbie, R

Anatomic position determines oncogenic specificity in melanoma by Weiss, JM, Hunter, MV, Cruz, NM, Baggiolini, A, Tagore, M, Ma, Y, Misale, S, Marasco, M, Simon-Vermot, T, Campbell, NR, Newell, F, Wilmott, JS, Johansson, PA, Thompson, JF, Long, GV, Pearson, JV, Mann, GJ, Scolyer, RA, Waddell, N, Montal, ED, Huang, T-H, Jonsson, P, Donoghue, MTA, Harris, CC, Taylor, BS, Xu, T, Chaligné, R, Shliaha, PV, Hendrickson, R, Jungbluth, AA, Lezcano, C, Koche, R, Studer, L, Ariyan, CE, Solit, DB, Wolchok, JD, Merghoub, T, Rosen, N, Hayward, NK, White, RM